Today's guest is Chris Joynt, Director of Product Marketing at Securiti. Securiti is a leader in AI-powered data security, privacy, and governance across hybrid and multi-cloud environments. Chris joins Emerj Editorial Director Matthew DeMello to explore why trust in data remains the defining challenge for AI in financial services, and how institutions can modernize their architectures to enable safe, compliant, and scalable AI adoption. Chris also breaks down the practical workflows that reduce regulatory and cyber risk — mapping data flows, classifying unstructured data, preventing shadow AI — and shows how stronger governance ultimately accelerates ROI by enabling faster, more reliable AI deployment across the enterprise. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast! This episode is sponsored by Securiti.

Shefali Kakar, Global Head of PK Sciences and Oncology at Novartis, returns to the AI in Business podcast to discuss how AI is reshaping the earliest and most critical phases of drug development—where strategic investment decisions are made long before a clinical trial begins. Together with Emerj Editorial Director Matthew DeMello, Shefali explores how advanced modeling, in silico design, and patient data are creating a clearer picture of risk and return across R&D portfolios. She explains how pharmaceutical organizations are leveraging multi-factorial models to simulate safety, efficacy, and market potential—down to the molecular level. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Today's guest is Cody Barrow, CEO at EclecticIQ. EclecticIQ is a global cybersecurity leader specializing in threat intelligence technology. Cody joins Emerj Editorial Director Matthew DeMello to discuss how AI-driven analytics and automation are revolutionizing threat detection and response in enterprise cybersecurity. Barrow also highlights practical improvements in workflow automation, early threat identification, and measurable ROI through reduced breach risks and operational efficiency. This episode is sponsored by EclecticIQ. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Today's guest is Dirk Michiels, CEO of Savaco. Savaco is a Belgium-based managed service provider specializing in hybrid cloud solutions, cybersecurity, and enterprise software deployment. Michiels joins Emerj Editorial Director Matthew DeMello to discuss the transformative role of hybrid cloud architectures in enterprise data and AI strategies. He also highlights how seamless integration, enhanced security protocols, and optimized deployment workflows lead to faster innovation and measurable ROI for modern organizations. This episode is sponsored by Xurrent. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Today's guest is Meghna Punhani, Chief People Officer at Eightfold AI. Eightfold AI provides an AI-powered platform for talent management, helping organizations optimize hiring, internal mobility, and workforce development. Meghna joins Emerj Editorial Director Matthew DeMello to discuss how HR leaders can adopt AI responsibly to enhance workforce capabilities and drive strategic impact. She also shares practical insights on reengineering HR workflows, leveraging AI for candidate screening and internal mobility, and building human-centered ethical guardrails for AI implementation. This episode is sponsored by Eightfold AI. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Today's guest is Mathew Paruthickal, Global Head of Data Architecture, Utilization, and AI Engineering at Sanofi. Founded in 1973, Sanofi is a French multinational pharmaceutical and healthcare company. Sanofi works in the research, development, and manufacturing of pharmaceuticals and vaccines. Mathew joins Emerj Editorial Director Matthew DeMello to explore how life sciences organisations can move from isolated digital tools to orchestrated, interoperable systems and how engineering teams can bake in traceability, auditability, and human-in-the-loop governance from day one. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Today's guest is Lauren Tulloch, Vice President and Managing Director at CCC (Copyright Clearance Center). CCC provides collective copyright licensing services for corporate and academic users of copyrighted materials, and, as one can imagine, the advent of AI has exposed a large number of businesses to copyright risks they've never considered before. Today, Lauren joins us to discuss where copyright exposure arises in financial services, from the growth of AI development to more commonplace employee use. With well over a decade at the company, Lauren dives into the urgent need for proactive copyright strategies in financial services, ensuring firms avoid litigation, regulatory scrutiny, and reputational damage, all while maximizing the value of AI. This episode is sponsored by CCC. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today's guest is Suvaleena Paul, Assistant Vice President and Senior Analyst in Fraud, Innovation, and Analysis at Bank of America. Suvaleena joins Emerj Editorial Director Matthew DeMello to discuss the integration of AI-driven technologies into fraud prevention workflows. She also shares practical insights on improving threat identification speed, fostering cross-team collaboration, and continuously refining AI models to maximize ROI and maintain regulatory compliance. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Today's guest is Dr. Mark Kiel, Chief Science Officer and Founder at Genomenon. Genomenon is a genomics intelligence company that unlocks real-world evidence from biomedical literature to help pharmaceutical and clinical diagnostics companies inform precision medicine, accelerate patient diagnosis, and guide trial design and label expansion. Mark joins Emerj Editorial Director Matthew DeMello to explore how AI can streamline the extraction, organization, and interpretation of genomic and clinical data, enabling faster, more accurate decision-making in pharmaceutical R&D. He also shares practical approaches to integrating AI with human curation, improving workflow efficiency, and scaling insights for rare disease diagnosis, trial design, and drug development strategy. This episode is sponsored by Genomenon. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

The gap between a promising AI pilot and enterprise-wide, scalable impact remains a critical divide where momentum and resources often stall. Today's guest is Deborah Golden, U.S. Chief Innovation Officer at Deloitte who returns to the show to join Emerj CEO Daniel Faggella to tackle the costly reality of stalled AI initiatives. This conversation moves beyond traditional theory, offering a new strategic lens for driving the systemic and cultural change required to scale AI responsibly. Deborah shares how leaders can overcome deep-seated organizational inertia that typically hinders initiatives, architecting novel approaches for innovation – like AI sandboxes, portfolio-based funding, and "blameless postmortems" – forging the critical, and often missing, connective tissue between experimentation and measurable business impact. The conversation delivers concrete strategies for connecting innovation to core operations and unlocking the promise of AI across your enterprise. This episode is sponsored by Deloitte. Discover how your company can connect with Emerj's audience through our curated media offerings: emerj.com/ad1. Share your perspective with an audience of enterprise AI decision-makers — apply to join the AI in Business podcast: emerj.com/expert2.